Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 11, Number 1—January 2005

Research

Demand for Prophylaxis after Bioterrorism-Related Anthrax Cases, 2001

Edward A. Belongia*Comments to Author , Burney Kieke*, Ruth Lynfield†, Jeffrey P. Davis‡, and Richard E. Besser§
Author affiliations: *Marshfield Clinic Research Foundation, Marshfield, Wisconsin, USA; †Minnesota Department of Health, Minneapolis, Minnesota, USA; ‡Wisconsin Division of Public Health, Madison, Wisconsin, USA; §Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Table

Characteristics of Minnesota and Wisconsin clinicians who received requests for antimicrobial agents to prevent anthrax during the last quarter of 2001

Received requests (%) p value
Prescriber type
Physician 52/157 (33) <0.001
Nonphysician 6/52 (12)
Practice location
Metropolitan area 22/82 (27) 0.82
Nonmetropolitan area 36/128 (28)
State
Minnesota 29/105 (28) 1.0
Wisconsin 29/105 (28)
Physician specialty*
Family practice 26/62 (41) 0.61
Internal medicine 14/42 (30)
Pediatrics 8/28 (28)
Emergency medicine 2/5 (33)

*Nine physicians who listed 2 specialties and 2 who listed “other” as a specialty were excluded from the frequency distribution for physician specialty.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO